The US FDA could re-inspect the three facilities of Ipca Laboratories that are under the regulator’s import alert, in September. In the first half of the next fiscal there could be an inspection but it is difficult to say when the FDA officials will come for an inspection, said a Cogencis report quoting the investor conference call meet. Investors will closely monitor the development, as the resolution at these units would lead to a significant increase in product approvals.
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.